Establishment profile
Novartis Pharmaceuticals Corporation
59 Route 10, EAST HANOVER, NJ, 07936
325412 — Pharmaceutical Preparation Manufacturing
EIN 221857084
Summary
Novartis Pharmaceuticals Corporation has no OSHA inspection history on file. Federal records covering wage, environmental, labor relations, and other agencies are noted below where present.
The most recent federal enforcement activity was recorded 0 days ago.
Federal records were found in 1 of 15 sources. Sources without matching records returned empty for this establishment.
Agency coverage
Novartis Pharmaceuticals Corporation appears in EPA environmental compliance, OFLC visa and labor certification (historical), FMCSA motor carrier registration, and UVA Corporate Prosecution Registry records only. No matching records were found in OSHA workplace safety, WHD wage enforcement, MSHA mine safety, NLRB labor relations, SAM.gov federal debarment, CMS nursing home enforcement, CPSC product recalls, or NHTSA vehicle recalls.
OSHA workplace safety
No OSHA inspections, citations, or accidents on file for Novartis Pharmaceuticals Corporation. Verify directly with Occupational Safety and Health Administration →
Safety self-report (OSHA 300A)
Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.
Reported for 3,621 average annual employees at this establishment.
Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.
Industry benchmark
BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.
OSHA severe injury reports
Self-reported events under 29 CFR 1904.39 (24-hour notification of hospitalization, amputation, or loss of an eye) · Aug 2015 – May 2025 · 1 in last 5 years
Most frequent event: Fall on same level due to slip or trip
Source: OSHA Severe Injury Reports (federal OSHA only; state-plan states like California, Oregon, and Washington maintain their own programs and do not consistently report into this feed).
Severe injury reports — events
Each row is a hospitalization, amputation, or eye-loss event the employer self-reported to OSHA under 29 CFR 1904.39. Narratives are written by the reporting employer.
| Date | Event | Body part | Outcome | |
|---|---|---|---|---|
| May 31, 2025 | Fall on same level due to slip or trip | Ankle(s) | Hospitalized | |
| Aug 26, 2015 | Other animal bites, nonvenomous | Nonclassifiable | Hospitalized |
Source: OSHA Severe Injury Reports. Federal-OSHA jurisdiction only by default; some state-plan programs report voluntarily.
Activity timeline
Most recent federal enforcement activity recorded 0 days ago. Data on this page is refreshed weekly.
Wage & Hour Division (WHD)
No WHD wage, overtime, or child-labor enforcement cases on file for Novartis Pharmaceuticals Corporation. Verify directly with Wage and Hour Division →
Mine safety (MSHA)
No MSHA mine safety violations on file for Novartis Pharmaceuticals Corporation. Verify directly with Mine Safety and Health Administration →
Labor relations (NLRB)
No NLRB unfair labor practice charges or union representation cases on file for Novartis Pharmaceuticals Corporation. Verify directly with National Labor Relations Board →
Visa & labor certification (OFLC) — historical
Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage. Historical data only: DOL ended OFLC Performance Data Disclosure publication in 2026, so the figures above reflect filings through the last ingested cycle and are not being refreshed. Treat as a historical snapshot, not a current signal.
Environmental compliance (EPA)
EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act. Status: Significant Violation.
EPA-registered facilities
Every EPA ECHO facility associated with this employer, sorted most-significant first. Each row links to EPA’s Detailed Facility Report for the source-of-truth record. Permits column lists active programs (Air = Clean Air Act, Water = Clean Water Act, RCRA = hazardous waste, TRI = Toxics Release Inventory reporting). 3 facilities · 1 significant noncompliance · 1 marked inactive.
| Facility | Permits | Status | Inspections | Formal actions | Penalties | Last inspected | ECHO |
|---|---|---|---|---|---|---|---|
NOVARTIS PHARMACEUTICALS CORP 59 STATE ROUTE 10 · EAST HANOVER, NJ, 07936 | AirWaterRCRATRI | Significant Violation QNCR 12 | 4 | 0 | — | Oct 2025 | View → |
NOVARTIS PHARMACEUTICALS CORP 23 FARINELLA DR · EAST HANOVER, NJ, 07936 | RCRA | No Violation Identified | 3 | 0 | — | Dec 2024 | View → |
NOVARTIS PHARMACEUTICALS CORP 59 RT 10 · EAST HANOVER TWP, NJ, 07936 | Water | — | 0 | 0 | — | — | View → |
Source: EPA ECHO (Enforcement and Compliance History Online). Compliance status follows EPA’s own labels (“Sig Violation” = significant noncompliance; QNCR = quarters of noncompliance over the recent reporting window). Inactive facilities (struck through) retain historical enforcement records even after operations ceased.
Motor carrier safety (FMCSA)
Federal Motor Carrier Safety Administration — DOT-regulated carrier registration and fleet data.
Federal criminal prosecution record
First case: 2011-01-28. Most recent: 2011-01-28. Source: UVA Corporate Prosecution Registry — federal pleas, DPAs, and NPAs.
Federal prosecution case file
Federal corporate prosecution records from the University of Virginia Corporate Prosecution Registry. DPA = Deferred Prosecution Agreement; NPA = Non-Prosecution Agreement; both are pre-trial settlements where the defendant accepts terms but avoids conviction. Monitor = court-appointed compliance oversight, usually 2-5 years. 1 case · 1 plea/conviction · $170,000,000 in penalties / restitution.
| Case | Date | Disposition | Crime | Jurisdiction | Total payment | Monitor |
|---|---|---|---|---|---|---|
USA v. NOVARTIS PHARMACEUTICALS CORPORATION Novartis Pharmaceuticals Corp. · NVS | Jan 2011 | plea | FDCA / Pharma | Pennsylvania - Eastern,USDOJ - Civil Division - Office of Consumer Litigation | $170,000,000 | No |
Source: University of Virginia Corporate Prosecution Registry (maintained by Prof. Brandon L. Garrett, Duke University). The registry has no state or jurisdiction-of-incorporation field on the company side, so same-name employers in different states may mis-attribute -- verify against the source case documents when precision matters.
Federal contracts
This location
Consolidated across all USAspending recipient entities under this corporate parent — not attributable to this single location.
Federal contract dollars to this establishment. Primary NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING. Last action: 2026-06-17. Source: USAspending.gov, net obligations. Recipient address is the SAM registration / HQ address, not necessarily the worksite.
In the news
Other employers in this industry and state
Other employers in pharmaceutical preparation manufacturing within NJ, ordered by federal enforcement volume:
- GUARDIAN DRUG COMPANYDAYTON — 3 federal enforcement records
- RARITAN PHARMACEUTICALSEAST BRUNSWICK — 3 federal enforcement records
- USPL NUTRITIONALS, LLCNORTH BRUNSWICK — 2 federal enforcement records
- MERCK & CO., INC.RAHWAY — 2 federal enforcement records
- WEST WARD PHARMACEUTICAL CORP.EATONTOWN — 2 federal enforcement records
- TEVA PHARMACEUTICALS USA INCFAIRFIELD — 2 federal enforcement records
- SIEGFRIED USA, INCPENNSVILLE — 2 federal enforcement records
- HIKMA PHARMACEUTICALSCHERRY HILL — 2 federal enforcement records
- NOVARTIS PHARMACEUTICALS CORPORATIONMORRIS PLAINS — 2 federal enforcement records
- G & W LABORATORIES, INC.SOUTH PLAINFIELD — 2 federal enforcement records
Related searches
- Pharmaceutical Preparation ManufacturingAll employers in this industry
- Employers in NJState-wide enforcement data
- Pharmaceutical Preparation Manufacturing in NJIndustry × state cross-filter
About this data
This profile aggregates federal enforcement records on Novartis Pharmaceuticals Corporation from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.
Establishments are matched across agencies using normalized employer name, state, and ZIP code.
OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.
Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.
Contact sales →Frequently asked
- What is Novartis Pharmaceuticals Corporation's OSHA violation history?
- Novartis Pharmaceuticals Corporation has no OSHA inspections on record.
- How does Novartis Pharmaceuticals Corporation's safety record compare to its industry?
- Novartis Pharmaceuticals Corporation operates in the pharmaceutical preparation manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. Novartis Pharmaceuticals Corporation's self-reported DART rate is 0.06 compared to an industry average of 0.9.